Bio-Path Holdings, Inc. BPTH OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score

39/100

1/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Bio-Path Holdings, Inc. (BPTH) , 前瞻盈利收益率 2,500.00%.

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。
前瞻市盈率 0.0

SharesGrow 综合评分： 36/100 其中 1/7 项标准通过。

SharesGrow 7-Criteria Score

39/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

✓

未來

100/100

Analyst consensus

→ Forecast

✗

过去

0/100

→ Income

健康

50/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

28/100

→ Income

✗

成长

15/100

→ Income

—

收入

N/A

No coverage

估值概览 — BPTH

估值倍数

P/E (TTM)0.0

前瞻 P/E0.0

PEG 比率N/A

前瞻 PEG0.00

P/B 比率0.00

P/S 比率0.00

EV/EBITDA0.0

每股数据

EPS (TTM)$-4.12

前瞻 EPS（预估）$1.50

每股账面价值$0.00

每股营收$0.00

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

Forward Earnings Yield2,500.00%

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2015	$-243.61	$0.00	$-5.47M	-
2016	$-291.26	$13K	$-6.75M	-51923.1%
2017	$-278.69	$37K	$-7.02M	-18981.1%
2018	$-287.54	$0.00	$-8.58M	-
2019	$-64.02	$0.00	$-8.51M	-
2020	$-56.44	$0.00	$-10.86M	-
2021	$-31.04	$0.00	$-10.44M	-
2022	$-38.03	$0.00	$-13.84M	-
2023	$-33.64	$0.00	$-16.08M	-
2024	$-4.12	$0.00	$-9.89M	-